Literature DB >> 21283476

[Not Available].

J Y Lang.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory disease of the connective tissue, affecting many organs of the body. The cause of SLE remains unknown, but the results of recent immunologic research have enlighted the characteristics of this disease and have contributed to improve the prognosis over the years. The renal and central nervous system involvement, as well as infection, remain high in the list of mortality causes. The usual treatment includes acetylsalicylic acid (ASA), antimalarials and corticosteroids. Main factors known to induce SLE are: sun exposures, pregnancy, therapeutic abortion, infection and several drugs.

Entities:  

Year:  1983        PMID: 21283476      PMCID: PMC2154274     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  5 in total

Review 1.  C-reactive protein in SLE.

Authors:  M B Pepys; J G Lanham; F C De Beer
Journal:  Clin Rheum Dis       Date:  1982-04

2.  Comparative effects of aspirin and ibuprofen in the management of systemic lupus erythematosus.

Authors:  J Karsh; R P Kimberly; N I Stahl; P H Plotz; J L Decker
Journal:  Arthritis Rheum       Date:  1980-12

3.  Salicylate hepatotoxicity in systemic lupus erythematosus: a common occurrence?

Authors:  R L Travers; G R Hughes
Journal:  Br Med J       Date:  1978-12-02

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.

Authors:  R P Kimberly; M D Lockshin; R L Sherman; J S McDougal; R D Inman; C L Christian
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.